Intriguingly, prolonged treatment of B16 melanoma cells with IFN-γ has been shown to confer resistance to radiotherapy and anti-CTLA-4 immunotherapy as a result of STAT1-related epigenetic events leading to up-regulation of immunosuppressive effectors and T-cell inhibitory receptors and their ligands [27]. The gene discussed is STAT1; the disease is melanoma.